Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by JimmyJon Jun 25, 2021 12:31pm
115 Views
Post# 33450798

RE:RE:RE:RE:RE:Never seen

RE:RE:RE:RE:RE:Never seen

Please sell your entire position now and come back in two years referencing this discussion.  We'll see who's really stupid then. 

JJ


StockingUp21 wrote:

I am stupid only stupid invest here. 

 

GameChangerBet wrote: "It’s hard to win an argument with a smart person, but it’s damn near impossible to win an argument with a stupid person" - Bill Murray
 

 

Forestview wrote: I think I speak for most of us here in that we never understand what you're saying, SU21.  Your grammar is so poor, and your words are non-sensical. 

Maybe spend more time focusing on proper writing before you spew the same baseless negative views over and over on here.  

StockingUp21 wrote: Paying more money because they are so slow so no bankruptcy is not success. 

 

 




<< Previous
Bullboard Posts
Next >>